Great Debate 2025 spotlights BIOLOX® delta ceramic and resurfacing

The Great Debate, organized by Profs. Justin Cobb (Imperial College London, UK) and Andrew Shimmin (Melbourne, Australia), gathered orthopedic surgeons and specialists from all over the world on 5-6 February at the Royal Society of Medicine in London.

Lead-free Piezoceramics for Medical Sensors and Devices

Amir R. Mirza, Ph.D., Sales Director of CeramTec UK Ltd, introduces in his second White Paper the recent developments of lead-free piezoceramic materials for medical sensors and devices.

Congratulations to the winners of the 2024 Heinz Mittelmeier Awards!

This year we had the pleasure to recognize two groups of honorees. Robert Nißler’s team evaluated the use of NIR-fluorescence in imaging that could improve ceramic fracture removal surgery. Meanwhile, a retrieval study conducted by Joachim Döring’s team analyzed wear-related damage to 43 BIOLOX®delta CoC and CoP components used in hard and soft bearings.

Change in the Management Board of CeramTec

CEO Dr Hadi Saleh takes over management of the Medical Division from Dr Katrin Sternberg in dual role

Pretty in Pink

Award for Dr. Phillip Damm at DKOU for exceptional research in hip joint replacement

Dr. Phillip Damm awarded 2023 Heinz Mittelmeier Research Award for significant contributions in hip arthroplasty research, reflecting Prof. Heinz Mittelmeier's legacy in orthopedic advancements

CeramTec receives FDA Breakthrough Device designation for novel ceramic knee project

The U.S. Food & Drug Administration (FDA) has confirmed that CeramTec’s novel ceramic total knee replacement device and proposed indication for use meet the criteria of a Breakthrough Device.

Award-winning Opharmic technology and CeramTec ceramics enable non-invasive drug delivery

Pioneering cooperation between Opharmic Technology and CeramTec.

Two-piece zirconia implant concepts are appropriate for clinical application

A review of the evaluation by ESCI of two-piece ceramic implant designs.